We are live on ! Find out more
PVMCI

Polaris Venture Management Co IV Portfolio holdings

AUM $62.4M
1-Year Est. Return 33.04%
This Fund
S&P 500
This Quarter Est. Return
+1.83%
1 Year Est. Return
+33.04%
3 Year Est. Return
+52.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$120M
AUM Growth
-$6.98M
Cap. Flow
-$7.31M
Cap. Flow %
-6.1%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$7.31M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLRN
1
DELISTED
Acceleron Pharma
XLRN
$91.2M 76.05%
2,396,389
-183,902
-7% -$7.31M
ALIM
2
DELISTED
Alimera Sciences
ALIM
$15.8M 13.15%
209,890
– –
DARE icon
3
Dare Bioscience
DARE
$18.3M
$13M 10.8%
11,979
– –

Similar funds

HCM
Hayman Capital Management Dallas, Texas $63.3M AUM 3.78% 1-Year Est. Return
LVP
Limestone Value Partners Houston, Texas $64M AUM 4.56% 1-Year Est. Return
SVP
Springbank Value Partners Hampton Bays, New York $65.5M AUM 35.56% 1-Year Est. Return
HWM
Heartwood Wealth Management London, United Kingdom $58.9M AUM 14.96% 1-Year Est. Return
CCG
Crescent Capital Group Los Angeles, California $56.8M AUM 11.67% 1-Year Est. Return
CSM
Central Square Management Naperville, Illinois $56.6M AUM 27.75% 1-Year Est. Return
KCP
Keane Capital Partners Charlotte, North Carolina $56M AUM
EL
Elberon LLC Austin, Texas $56M AUM 14.07% 1-Year Est. Return

Polaris Venture Management Co IV's Q1 2015 Portfolio in Review

As of Q1 2015, Polaris Venture Management Co IV held 3 positions worth $120M, down 5.5% from $127M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Polaris Venture Management Co IV withdrew a net $7.31M in Q1 2015, reducing 1 holding. Its largest reduction was Acceleron Pharma, cutting an estimated $7.31M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Polaris Venture Management Co IV's biggest Q1 2015 reduction was Acceleron Pharma, cutting an estimated $7.31M.
  • Polaris Venture Management Co IV's ten largest holdings make up 100% of its $120M portfolio in Q1 2015.
  • Polaris Venture Management Co IV opened 0 new positions and closed 0 in Q1 2015.
  • Polaris Venture Management Co IV's portfolio value fell 5.5% quarter-over-quarter to $120M.

Based on Polaris Venture Management Co IV's 13F filing for Q1 2015, filed 14 May 2015.